HIMS (Hims & Hers Health) Stock Based Compensation: $147 Mil (TTM As of Mar. 2026)


HIMS Hims & Hers Health Inc HIMS
81 GF Score
Price $36.17
GF Value $39.16
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Stock Based Compensation?

Hims & Hers Health HIMS -5.51% 81 Stock Based Compensation is $147 Mil as of Mar. 2026. GuruFocus rates HIMS with a GF Score™ of 81/100 and a GF Value™ of $39.16 (Fairly Valued). The stock has 3 warning signs investors should review.

Hims & Hers Health's Stock Based Compensation for the three months ended in Mar. 2026 was $37 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $147 Mil.

Hims & Hers Health Stock Based Compensation Related Terms

Hims & Hers Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Stock Based Compensation Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 67.21 42.82 66.08 92.32 135.24

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.86 35.73 40.17 34.49 36.86
HIMS
81GF Score
Hims & Hers Health Inc HIMS
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $147 Mil.

What does a Stock Based Compensation of $147 Mil mean?
Hims & Hers Health (HIMS) has a Stock Based Compensation of $147 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hims & Hers Health and its competitors.
Is Hims & Hers Health's Stock Based Compensation too high?
Hims & Hers Health's current Stock Based Compensation is $147 Mil. Overall, Hims & Hers Health has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Stock Based Compensation compare to LNTH and LQDA?
Hims & Hers Health's Stock Based Compensation of $147 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hims & Hers Health and its competitors. Hims & Hers Health's current Stock Based Compensation is $147 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Fairly Valued. The stock's GF Value™ is $39.16, compared to a current price of $36.17 — trading 7.6% below its estimated fair value. The current Stock Based Compensation is $147 Mil. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Stock Based Compensation is $147 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of $36.17 is trading 7.6% below its estimated GF Value™ of $39.16. GuruFocus considers Hims & Hers Health to be Fairly Valued.

Key valuation signals for HIMS:

  • Stock Based Compensation: $147 Mil
  • GF Value™: $39.16 vs. price of $36.17 (7.6% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Other Exchanges HIMS:Mexico82W:Germany
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for HIMS

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$36.17
Price
$39.16
GF Value